155 related articles for article (PubMed ID: 9056022)
1. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
[TBL] [Abstract][Full Text] [Related]
2. TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.
Poirel L; Mammeri H; Nordmann P
Antimicrob Agents Chemother; 2004 Dec; 48(12):4528-31. PubMed ID: 15561821
[TBL] [Abstract][Full Text] [Related]
3. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
Stürenburg E; Kühn A; Mack D; Laufs R
J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
[TBL] [Abstract][Full Text] [Related]
4. In vitro selection and characterization of mutants in TEM-1-producing Escherichia coli by ceftazidime and ceftibuten.
Perilli M; Segatore B; Tavio M; Setacci D; Celenza G; De Santis F; Pellegrini C; Rossolini GM; Amicosante G
J Chemother; 2007 Apr; 19(2):123-6. PubMed ID: 17434819
[TBL] [Abstract][Full Text] [Related]
5. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.
Rasheed JK; Jay C; Metchock B; Berkowitz F; Weigel L; Crellin J; Steward C; Hill B; Medeiros AA; Tenover FC
Antimicrob Agents Chemother; 1997 Mar; 41(3):647-53. PubMed ID: 9056008
[TBL] [Abstract][Full Text] [Related]
6. A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.
Kurokawa H; Shibata N; Doi Y; Shibayama K; Kamachi K; Yagi T; Arakawa Y
Antimicrob Agents Chemother; 2003 Sep; 47(9):2981-3. PubMed ID: 12937007
[TBL] [Abstract][Full Text] [Related]
7. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
Chouchani C; Ben-Achour N; M'charek A; Belhadj O
C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
[TBL] [Abstract][Full Text] [Related]
8. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and genetic characteristics of TEM-29B, a novel extended spectrum beta-lactamase.
Bou G; Martínez-Beltrán J; Cerveró G; Pérez-Díaz JC
FEMS Microbiol Lett; 1999 May; 174(1):185-90. PubMed ID: 10234838
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
Chanal CM; Sirot DL; Labia R; Petit A; Morand A; Sirot JL; Cluzel RA
Antimicrob Agents Chemother; 1988 Nov; 32(11):1660-5. PubMed ID: 3075436
[TBL] [Abstract][Full Text] [Related]
11. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
Lemozy J; Sirot D; Chanal C; Huc C; Labia R; Dabernat H; Sirot J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2580-2. PubMed ID: 8585751
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.
Gniadkowski M; Schneider I; Jungwirth R; Hryniewicz W; Bauernfeind A
Antimicrob Agents Chemother; 1998 Mar; 42(3):514-20. PubMed ID: 9517925
[TBL] [Abstract][Full Text] [Related]
13. TEM-28 from an Escherichia coli clinical isolate is a member of the His-164 family of TEM-1 extended-spectrum beta-lactamases.
Bradford PA; Jacobus NV; Bhachech N; Bush K
Antimicrob Agents Chemother; 1996 Jan; 40(1):260-2. PubMed ID: 8787920
[TBL] [Abstract][Full Text] [Related]
14. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
[TBL] [Abstract][Full Text] [Related]
15. AmpC beta-lactamase in an Escherichia coli clinical isolate confers resistance to expanded-spectrum cephalosporins.
Mammeri H; Nazic H; Naas T; Poirel L; Léotard S; Nordmann P
Antimicrob Agents Chemother; 2004 Oct; 48(10):4050-3. PubMed ID: 15388478
[TBL] [Abstract][Full Text] [Related]
16. Development of extended-spectrum activity in TEM beta-lactamases in hyper-mutable, mutS Escherichia coli.
Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
Clin Microbiol Infect; 2006 Aug; 12(8):800-3. PubMed ID: 16842578
[TBL] [Abstract][Full Text] [Related]
17. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate.
Sirot D; Recule C; Chaibi EB; Bret L; Croize J; Chanal-Claris C; Labia R; Sirot J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1322-5. PubMed ID: 9174192
[TBL] [Abstract][Full Text] [Related]
18. TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli.
Paul GC; Gerbaud G; Bure A; Philippon AM; Pangon B; Courvalin P
Antimicrob Agents Chemother; 1989 Nov; 33(11):1958-63. PubMed ID: 2692515
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
Hibbert-Rogers LC; Heritage J; Gascoyne-Binzi DM; Hawkey PM; Todd N; Lewis IJ; Bailey C
J Antimicrob Chemother; 1995 Jul; 36(1):65-82. PubMed ID: 8537285
[TBL] [Abstract][Full Text] [Related]
20. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
Clasen J; Birkegård AC; Græsbøll K; Folkesson A
J Glob Antimicrob Resist; 2019 Dec; 19():32-39. PubMed ID: 31048029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
